Abstract
Non-small cell lung cancer (NSCLC) is an aggressive and rapidly expanding lung cancer. Abnormal upregulation or knockdown of PDIA6 expression can predict poor prognosis in various cancers. This study aimed to investigate the biological function of PDIA6 in NSCLC. SOX2 and PDIA6 expression in NSCLC tissues and regulatory relationship between them were analyzed using bioinformatics. GSEA was performed on the enrichment pathway of PDIA6. qRT-PCR was utilized to examine expression of SOX2 and PDIA6 in NSCLC tissues and cells, and dual-luciferase reporter assay and ChIP experiments were performed to validate their regulatory relationship. CCK-8 experiment was conducted to assess cell viability, western blot was to examine levels of stem cell markers and proteins related to aerobic glycolysis pathway in cells. Cell sphere formation assay was used to evaluate efficiency of cell sphere formation. Reagent kits were used to measure glycolysis levels and glycolysis products. High expression of PDIA6 in NSCLC was linked to aerobic glycolysis. Knockdown of PDIA6 reduced cell viability, expression of stem cell surface markers, and cell sphere formation efficiency in NSCLC. Overexpression of PDIA6 could enhance cell viability and promote aerobic glycolysis, but the addition of 2-DG could reverse this result. Bioinformatics predicted the existence of upstream transcription factor SOX2 for PDIA6, and SOX2 was significantly upregulated in NSCLC, and they had a binding relationship. Further experiments revealed that PDIA6 overexpression restored repressive effect of knocking down SOX2 on aerobic glycolysis and cell stemness. This work revealed that the SOX2/PDIA6 axis mediated aerobic glycolysis to promote NSCLC cell stemness, providing new therapeutic strategies for NSCLC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
The data and materials in the current study are available from the corresponding author on reasonable request.
References
Bai Y, Liu X, Qi X, Liu X, Peng F, Li H et al (2019) PDIA6 modulates apoptosis and autophagy of non-small cell lung cancer cells via the MAP4K1/JNK signaling pathway. EBioMedicine 42:311–325
Bi L, Ren Y, Feng M, Meng P, Wang Q, Chen W et al (2021) HDAC11 regulates Glycolysis through the LKB1/AMPK Signaling Pathway to maintain Hepatocellular Carcinoma Stemness. Cancer Res 81:2015–2028
Cai S, Li N, Bai X, Liu L, Banerjee A, Lavudi K et al (2022) ERK inactivation enhances stemness of NSCLC cells via promoting slug-mediated epithelial-to-mesenchymal transition. Theranostics 12:7051–7066
Chaudhary S, Islam Z, Mishra V, Rawat S, Ashraf GM, Kolatkar PR (2019) Sox2: a Regulatory factor in Tumorigenesis and metastasis. Curr Protein Pept Sci 20:495–504
Fujimoto J, Wistuba II (2014) Current concepts on the molecular pathology of non-small cell lung carcinoma. Semin Diagn Pathol 31:306–313
He H, Xiao L, Wang J, Guo D, Lu Z (2023) Aerobic glycolysis promotes tumor immune evasion and tumor cell stemness through the noncanonical function of hexokinase 2. Cancer Commun (Lond) 43:387–390
Kasashima H, Duran A, Martinez-Ordonez A, Nakanishi Y, Kinoshita H, Linares JF et al (2021) Stromal SOX2 Upregulation promotes tumorigenesis through the generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population. Dev Cell 56:95–110e10
Kikuchi M, Doi E, Tsujimoto I, Horibe T, Tsujimoto Y (2002) Functional analysis of human P5, a protein disulfide isomerase homologue. J Biochem 132:451–455
Li SN, Wu JF (2020) TGF-beta/SMAD signaling regulation of mesenchymal stem cells in adipocyte commitment. Stem Cell Res Ther 11:41
Ma Y, Xia P, Wang Z, Xu J, Zhang L, Jiang Y (2021) PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of beta-catenin and PD-L1. Neoplasia 23:912–928
Ma Y, Zhu Y, Shang L, Qiu Y, Shen N, Wang J et al (2023) LncRNA XIST regulates breast cancer stem cells by activating proinflammatory IL-6/STAT3 signaling. Oncogene 42:1419–1437
Mamun MA, Mannoor K, Cao J, Qadri F, Song X (2020) SOX2 in cancer stemness: tumor malignancy and therapeutic potentials. J Mol Cell Biol 12:85–98
Mao L, Wu X, Gong Z, Yu M, Huang Z (2021) PDIA6 contributes to aerobic glycolysis and cancer progression in oral squamous cell carcinoma. World J Surg Oncol 19:88
Meshulami N, Tavolacci S, de Miguel-Perez D, Rolfo C, Mack PC, Hirsch FR (2023) Predictive capability of PD-L1 protein expression for patients with Advanced NSCLC: any differences based on histology? Clin Lung Cancer 24:401–406
Mestre-Farras N, Guerrero S, Bley N, Rivero E, Coll O, Borras E et al (2022) Melanoma RBPome identification reveals PDIA6 as an unconventional RNA-binding protein involved in metastasis. Nucleic Acids Res 50:8207–8225
Novak D, Huser L, Elton JJ, Umansky V, Altevogt P, Utikal J (2020) SOX2 in development and cancer biology. Semin Cancer Biol 67:74–82
Pajak B, Siwiak E, Soltyka M, Priebe A, Zielinski R, Fokt I et al (2019) 2-Deoxy-d-Glucose and its analogs: from Diagnostic to Therapeutic agents. Int J Mol Sci. ; 21
Rao CV, Mohammed A (2015) New insights into pancreatic cancer stem cells. World J Stem Cells 7:547–555
Rodriguez-Canales J, Parra-Cuentas E, Wistuba II (2016) Diagnosis and molecular classification of Lung Cancer. Cancer Treat Res 170:25–46
Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17–48
Sikandar SS, Pate KT, Anderson S, Dizon D, Edwards RA, Waterman ML et al (2010) NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer. Cancer Res 70:1469–1478
Sun WH, Chen YH, Lee HH, Tang YW, Sun KH (2022) PDK1- and PDK2-mediated metabolic reprogramming contributes to the TGFbeta1-promoted stem-like properties in head and neck cancer. Cancer Metab 10:23
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249
Takebe N, Miele L, Harris PJ, Jeong W, Bando H, Kahn M et al (2015) Targeting notch, hedgehog, and wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol 12:445–464
Tang Q, Chen J, Di Z, Yuan W, Zhou Z, Liu Z et al (2020) TM4SF1 promotes EMT and cancer stemness via the Wnt/beta-catenin/SOX2 pathway in colorectal cancer. J Exp Clin Cancer Res 39:232
Wang L, Wang X, Wang CC (2015) Protein disulfide-isomerase, a folding catalyst and a redox-regulated chaperone. Free Radic Biol Med 83:305–313
Wang X, Chen Y, Wang X, Tian H, Wang Y, Jin J et al (2021) Stem cell factor SOX2 confers ferroptosis resistance in Lung Cancer via Upregulation of SLC7A11. Cancer Res 81:5217–5229
Wang J, Shao F, Yang Y, Wang W, Yang X, Li R et al (2022) A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability. Cancer Commun (Lond) 42:1008–1027
Xie Q, Zhao S, Liu W, Cui Y, Li F, Li Z et al (2021) YBX1 enhances metastasis and stemness by transcriptionally regulating MUC1 in Lung Adenocarcinoma. Front Oncol 11:702491
Xu Q, Zhang Q, Ishida Y, Hajjar S, Tang X, Shi H et al (2017) EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect. Oncotarget 8:9557–9571
Yan C, Song X, Wang S, Wang J, Li L (2020) Knockdown of PDIA6 inhibits cell proliferation and enhances the Chemosensitivity in Gastric Cancer cells. Cancer Manag Res 12:11051–11062
Yu JM, Sun W, Wang ZH, Liang X, Hua F, Li K et al (2019) TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription. Nat Commun 10:5720
Zhu T, Zheng J, Zhuo W, Pan P, Li M, Zhang W et al (2021) ETV4 promotes breast cancer cell stemness by activating glycolysis and CXCR4-mediated sonic hedgehog signaling. Cell Death Discov 7:126
Funding
This work was supported by Youth Innovative Research Project of Sichuan Medical Association (No.Q21034).
Author information
Authors and Affiliations
Contributions
Conceptualization & Methodology: YT, ZY, CJ. Investigation & Resources: GS, LT, XJ. Supervision: YJ, AH, YB. Data Curation, Visualization & Software: YT, ZY, CJ. Writing-Original Draft: XW, DM. Writing-Review & Editing: XW, DM.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wan, X., Ma, D., Song, G. et al. The SOX2/PDIA6 axis mediates aerobic glycolysis to promote stemness in non-small cell lung cancer cells. J Bioenerg Biomembr 56, 323–332 (2024). https://doi.org/10.1007/s10863-024-10009-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-024-10009-y